Abstract:(ProQuest: ... denotes formula omitted.) Abstract Objective: To investigate the association between the tryptophan hydroxylase-2 (TPH2) gene (G1463A) polymorphism and unipolar depression in a southern Chinese Han population. Participants and Methods: The allelic and genotypic frequencies of TPH2 gene G1463A polymorphism were examined with the amplification refractory mutation system-polymerase chain reaction technique in 123 unipolar depressive patients and 122 healthy individuals. Patients and healthy controls were all from the Guangdong Han population in southern China. Results: No subjects among the cases or controls were found to carry any TPH2 1463A allele. Conclusion: There is no association identified between the TPH2 G1463A polymorphism and unipolar depression in the southern Chinese Han population. Key words: Genes; Mood disorders; Polymorphism, genetic; Tryptophan hydroxylase Introduction Depression is a common psychiatric disease which may lead to mental disability and suicide. The life-time prevalence of depression is about 5 to 17%.1 The incidence of depression is highly modulated with environmental factors, however, there is also a strong genetic contribution to the disease pathogenesis with an estimated heritability of 40 to 70%.1 Family studies, twin studies, and foster children studies show an association between genetic factors and depression.2 Until now, there are still no confirmed genes or related DNA sequences associated with the onset of depression. Therefore, studies to identify the genetic associations of depression will be an interesting area of concern. Results from psychopharmacology and neurobehavioural research show serotonin (5- hydroxytryptamine [5-HT]) dysfunction in the central nervous system is associated with the incidence of depression.2 Decreased level of 5-HT is associated with depressed mood, reduced appetite, insomnia, circadian rhythm disturbance, endocrine and sexual dysfunction, anxiety, and reduced activity.3 Furthermore, the central serotonin neural system is the target for most commonly prescribed antidepressants such as tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), and monoamine oxidase inhibitors.4 Central serotonin is synthesised at dorsal raphe nuclei of the brainstem.5 The biological processes related to serotonin in the body include its biosynthesis, storage, transportation, release, receptor binding, reuptake, and metabolism. Proteins and corresponding related genes which regulate these processes include tryptophan hydroxylase-1 and -2 (TPH1 and TPH2), vesicular monoamine transporter 2 (VMAT2), serotonin transporter (5-HTT), monoamine oxidase A (MAOA), and the serotonin receptors including: 5-HT1A, -2A, -2C, -3, -4, -5, -6, -7.6 Therefore, these serotonin-related genes are the candidates for research into the aetiology of depression. Tryptophan hydroxylase is the rate-limiting enzyme of 5-HT biosynthesis, which includes TPH1 and TPH2. The former (TPH1) is predominately expressed in peripheral organs such as the heart, lungs, duodenum, liver, and adrenal glands, and also in some parts of the brain. It is also the main regulator of peripheral 5-HT synthesis. The latter (TPH2) is neuron-specific and only expressed in the brain 5-HT neuron. In some regions of the brain (such as the hippocampus, frontal lobe, thalamus, hypothalamus, and amygdala), the expression levels of TPH1 and TPH2 are almost equal. However, TPH2 is predominately expressed in the brain stem where 5-HT neurons originate.7 Recent studies have shown inconsistent results regarding any association between TPH2 gene polymorphism and unipolar depression.8-16 In 2005, Zhang et al4 found that the human TPH2 gene coding region contains a functional polymorphism, G1463A, leading to the replacement of the 441 arginine position with histidine (R441H). This may cause approximately 80% of TPH2 function loss and significantly reduce 5-HT generation. …

Additive Effect of Tryptophan Hydroxylase 1 and Monoamine Oxidase A Gene on Negative Emotional Management in Depressive Frontal Subregions

The impact of tryptophan hydroxylase 1 gene and serotonin receptor 2A gene on emotional process in depressive frontal lobe

Tryptophan Hydroxylase Gene Polymorphism and the Imaging Manifestation in Subregions of Frontal Lobes in Patients with Depressive Disorder

Influence of monoamine oxidase A gene and brain function in the dynamic facial expression recognition in depressed patients

A preliminary study on the relationship of the monoamine oxidase A gene polymorphism and the gray matter concentration in patients with major depressive disorders

The Impacts of Anhedonia on Brain Functional Alterations in Patients with Major Depressive Disorder: A Resting-State Functional Magnetic Resonance Imaging Study of Regional Homogeneity.

Aberrant Interhemispheric Functional Connectivity in Major Depressive Disorder with and Without Anhedonia.

Association of APC and REEP5 Gene Polymorphisms with Major Depression Disorder and Treatment Response to Antidepressants in a Han Chinese Population

Association study on 5-HT 2A receptor gene T102C polymorphism and the concentration of gray matter in patients with major depressive disorder

No Association Between Tryptophan Hydroxylase-2 Gene G1463A Polymorphism and Unipolar Depression in a Southern Chinese Han Population (translated Version)

Effects of tumor necrosis factor-α polymorphism on the brain structural changes of the patients with major depressive disorder

Association Study of the Tph2 Gene with Major Depressive Disorder in the Han Chinese Population

Influence and interaction of resting state functional magnetic resonance and tryptophan hydroxylase-2 methylation on short-term antidepressant drug response

Association Analysis Between Mood Disorder and Monoamine Oxidase Gene

Meta-analysis of association between TPH2 single nucleotide poiymorphism and depression

Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression

Dopamine Multilocus Genetic Profile, Spontaneous Activity of Left Superior Temporal Gyrus, and Early Therapeutic Effect in Major Depressive Disorder

Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.

Serotonergic genes modulate amygdala activity in major depression

The influence of rs1360780 polymorphism of FK506-binding protein 5 gene on the brain regional homogeneity of resting state fMRI in patients with major depressive disorder

A central serotonin regulating gene polymorphism (TPH2) determines vulnerability to acute tryptophan depletion-induced anxiety and ventromedial prefrontal threat reactivity in healthy young men